Cancer treatments should depend on the type of tumor

PHARMACEUTICALS & BIOTECHNOLOGY EDITOR | July 10, 2018

article image
Traditionally, cancers have been treated according to the part of the body they are diagnosed in, like the breast, lungs, or bowel. But a new study from California’s Buck Institute for Research on Aging analyzed 33 cancer types and reclassified them into 28 molecular types, or ‘clusters’, based on the cell and genetic makeup of the cancers, and not where they originated.

Spotlight

Heng & Hurst - Pharmaceutical and Medical Devices

Heng & Hurst is an Australian and New Zealand specialist pharmaceutical and medical devices recruitment consultancy. We offer 17 combined years of expertise and experience. We are a dedicated team who are passionate about building and shaping high performing commercial teams. We bring our extensive industry knowledge to provide creative and appropriate recruitment solutions.

OTHER ARTICLES

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 4, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More
PHARMACY MARKET

A pharma outsourcing mission

Article | March 4, 2020

In a way, getting through the initial stages of a complex pharmaceutical project that is being outsourced to a contract development and manufacturing organization is like getting a rocket off the ground. Many drug developers express frustration with the time it often takes during the initial stages of working with a CDMO — from the time they first reach out to a CDMO for help until they receive a proposal. Some have described it as months of silence from when they send a request for proposal (RFP) until they have a proposal in hand. The initial stages of a relationship between drug sponsor and CDMO often do not get the attention it deserves, and valuable time is lost, delaying projects and delaying delivery of therapeutics to patients. The quick scheduling of the ACT meeting with the right attendees can deliver immediate answers to key questions needed by the drug sponsor for effective planning and can help propel projects to a successful launch.

Read More

The Future of Pharma Beyond Blockbusters

Article | March 4, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 4, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

Spotlight

Heng & Hurst - Pharmaceutical and Medical Devices

Heng & Hurst is an Australian and New Zealand specialist pharmaceutical and medical devices recruitment consultancy. We offer 17 combined years of expertise and experience. We are a dedicated team who are passionate about building and shaping high performing commercial teams. We bring our extensive industry knowledge to provide creative and appropriate recruitment solutions.

Events